4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000140
Chief Medical Officer sold 1,272 shares at $16.30 ($20,734)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Geffner Michael Chief Medical Officer | 2025-10-08 | Sale | −1,272 | $16.30 | $20,734 | 220,553 | D |
| Open-market sales · 1,272 sh · avg $16.30 · $20,734 | |||||||
Loading xslF345X05/wk-form4_1760126587.xml…